These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31637544)

  • 1. Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy.
    Gesenberg C; Mathias NR; Xu Y; Crison J; Savant I; Saari A; Good DJ; Hemenway JN; Narang AS; Schartman RR; Zheng N; Buzescu A; Patel J
    Pharm Res; 2019 Oct; 36(12):164. PubMed ID: 31637544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound.
    Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P
    Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis.
    Good DJ; Hartley R; Mathias N; Crison J; Tirucherai G; Timmins P; Hussain M; Haddadin R; Koo O; Nikfar F; Fung NK
    Mol Pharm; 2015 Dec; 12(12):4434-44. PubMed ID: 26536519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using absorption simulation and gastric pH modulated dog model for formulation development to overcome achlorhydria effect.
    Mitra A; Kesisoglou F; Beauchamp M; Zhu W; Chiti F; Wu Y
    Mol Pharm; 2011 Dec; 8(6):2216-23. PubMed ID: 21981752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
    Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
    Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Gastrointestinal Simulator, Mass Transport Analysis, and Absorption Simulation to Investigate the Impact of pH Modifiers in Mitigating Weakly Basic Drugs' Performance Issues Related to Gastric pH: Palbociclib Case Study.
    Kuminek G; Salehi N; Waltz NM; Sperry DC; Greenwood DE; Hate SS; Amidon GE
    Mol Pharm; 2023 Jan; 20(1):147-158. PubMed ID: 36367432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
    Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
    Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug-Drug Interaction Caused by Acid-Reducing Agents.
    Matsui K; Tsume Y; Amidon GE; Amidon GL
    Mol Pharm; 2015 Jul; 12(7):2418-28. PubMed ID: 25985298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastric pH on the pharmacokinetics of a BCS class II compound in dogs: utilization of an artificial stomach and duodenum dissolution model and GastroPlus,™ simulations to predict absorption.
    Bhattachar SN; Perkins EJ; Tan JS; Burns LJ
    J Pharm Sci; 2011 Nov; 100(11):4756-65. PubMed ID: 21681753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using pH Gradient Dissolution with In-Situ Flux Measurement to Evaluate Bioavailability and DDI for Formulated Poorly Soluble Drug Products.
    Li J; Tsinman K; Tsinman O; Wigman L
    AAPS PharmSciTech; 2018 Oct; 19(7):2898-2907. PubMed ID: 30209787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir.
    Kambayashi A; Dressman JB
    J Pharm Sci; 2019 Jan; 108(1):584-591. PubMed ID: 30423339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389.
    Badawy SI; Gray DB; Zhao F; Sun D; Schuster AE; Hussain MA
    Pharm Res; 2006 May; 23(5):989-96. PubMed ID: 16715389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs.
    Tolbert MK; Graham A; Odunayo A; Price J; Steiner JM; Newkirk K; Hecht S
    J Vet Intern Med; 2017 Jan; 31(1):117-123. PubMed ID: 27906465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
    Pang J; Dalziel G; Dean B; Ware JA; Salphati L
    Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization.
    Saxena A; Shah D; Padmanabhan S; Gautam SS; Chowan GS; Mandlekar S; Desikan S
    Eur J Pharm Sci; 2015 Aug; 76():173-80. PubMed ID: 25960252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of ritonavir formulations and correlation to in vivo performance in dogs.
    Xu H; Krakow S; Shi Y; Rosenberg J; Gao P
    Eur J Pharm Sci; 2018 Mar; 115():286-295. PubMed ID: 29355594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.
    Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J
    J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.
    Lubach JW; Chen JZ; Hau J; Imperio J; Coraggio M; Liu L; Wong H
    Mol Pharm; 2013 Nov; 10(11):3997-4004. PubMed ID: 23961831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.